Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to 0.3.

  • Bioventus' Equity Ratio rose 2166.63% to 0.3 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3, marking a year-over-year increase of 2166.63%. This contributed to the annual value of 0.25 for FY2024, which is 649.59% down from last year.
  • According to the latest figures from Q3 2025, Bioventus' Equity Ratio is 0.3, which was up 2166.63% from 0.28 recorded in Q2 2025.
  • Bioventus' Equity Ratio's 5-year high stood at 0.5 during Q4 2021, with a 5-year trough of 0.24 in Q2 2024.
  • Its 5-year average for Equity Ratio is 0.31, with a median of 0.28 in 2023.
  • Per our database at Business Quant, Bioventus' Equity Ratio soared by 7002.31% in 2021 and then crashed by 3941.63% in 2022.
  • Bioventus' Equity Ratio (Quarter) stood at 0.5 in 2021, then crashed by 39.42% to 0.3 in 2022, then fell by 9.2% to 0.27 in 2023, then dropped by 6.5% to 0.25 in 2024, then increased by 15.86% to 0.3 in 2025.
  • Its Equity Ratio was 0.3 in Q3 2025, compared to 0.28 in Q2 2025 and 0.27 in Q1 2025.